Galenica Aktie
72,90CHF | 0,10CHF | 0,14% |
WKN DE: A2DN0K / ISIN: CH0360674466
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,44 |
UBS Asset Management Switzerland AG | 5,34 |
Credit Suisse Asset Management (Schweiz) AG | 4,99 |
Alecta Pension Insurance Mutual | 4,00 |
Government Pension Fund - Global (The) | 2,56 |
Vanguard Total International Stock Index Fund | 1,36 |
UBS (CH) Equity Fund - Mid Caps Switzerland (CHF) | 0,91 |
Vanguard Developed Markets Index Fund | 0,84 |
Swisscanto (CH) Index Fund V - Equity Fd. Switzerland To. Res. | 0,75 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 5 449 | 5 538 | 5 533 | 5 728 | 5 907 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,61 | 0,63 | 0,69 | 0,70 | 0,63 |
Bilanz (in Mio. CHF) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 823 | 812 | 963 | 977 | 1 034 |
Summe Anlagevermögen | 1 387 | 1 447 | 1 652 | 1 687 | 2 009 |
Summe Aktiva | 2 210 | 2 259 | 2 616 | 2 664 | 3 042 |
Bilanz (in Mio. CHF) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 1 210 | 1 206 | 1 382 | 1 414 | 1 567 |
Summe Eigenkapital | 1 000 | 1 053 | 1 234 | 1 249 | 1 475 |
Summe Passiva | 2 210 | 2 259 | 2 616 | 2 664 | 3 042 |
Adresse
Untermattweg 8, 3027 Bern | |
Telefon | +41 (58) 852-81-11 |
Internet | http://www.galenica.com |
Management
Andreas Stefan Walde
Independent Director |
Barbara Wälchli
Secretary & General Counsel |
Bertrand Jungo
Independent Director |
Daniele Madonna
Chief Healthcare Officer |
Etienne Jornod
Honorary Chairman |
Felix Fritz Burkhard
Chief Financial Officer |
Judith Meier
Independent Director |
Jörg Zulauf
Independent Director |
Jürg Pauli
Chief Transformation Officer |
Lukas Ackermann
Chief IT & Digital Services Officer |
Marc Werner
Chief Executive Officer |
Marianne Hasler
Chief People & Culture |
Markus Rudolf Neuhaus
Independent Chairman |
Pascale Bruderer
Vice Chairman |
Solange Peters
Independent Director |
Thomas F. Szuran
Chief Products & Marketing Officer |
Virginie Pache
Chief Pharmacies Officer |